saikosaponin d has been researched along with glycosides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatterjee, N; Das, S; Kumar, D; Mallick, S; Pal, BC; Saha, KD | 1 |
| Chen, K; Gao, M; Jiang, H; Li, H; Ye, C; Yu, K | 1 |
2 other study(ies) available for saikosaponin d and glycosides
| Article | Year |
|---|---|
Effect of corchorusin-D, a saikosaponin like compound, on B16F10 melanoma cells (in vitro and in vivo).
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Caspase 9; Corchorus; Glycosides; Humans; Melanoma; Membrane Potential, Mitochondrial; Mice; Mitochondria; Molecular Structure; Oleanolic Acid; Saponins; Skin Neoplasms; Triterpenes | 2013 |
Glycan Epitopes and Potential Glycoside Antagonists of DC-SIGN Involved in COVID-19: In Silico Study.
Topics: Amino Acid Motifs; Binding Sites; Cell Adhesion Molecules; Computer Simulation; COVID-19; Cytokines; Epitopes; Flavanones; Glucosides; Glycosides; Humans; Lectins, C-Type; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Monosaccharides; Oleanolic Acid; Polysaccharides; Receptors, Cell Surface; Saponins; Spike Glycoprotein, Coronavirus | 2021 |